Divi's Laboratories Limited (BOM:532488)
9,580.00
+35.00 (0.37%)
At close: Oct 7, 2026
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 2.55 trillion as of October 7, 2026. Its market cap has increased by 64.56% in one year.
Market Cap
2.55T
Enterprise Value
2.51T
Revenue
112.30B
Global Rank
n/a
Country Rank
n/a
PE Ratio
87.02
ChartMarket Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 2.55T, an increase of 124,945.09%. That is a compound annual growth rate of 35.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 2.55T | 49.99% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 275.80B |
| Shilpa Medicare | 208.03B |
| Suven Life Sciences | 87.17B |
| Symbiotec Pharmalab | 76.98B |
| IOL Chemicals and Pharmaceuticals | 61.48B |
| Gujarat Themis Biosyn | 49.76B |
| NGL Fine-Chem | 18.07B |
| Bajaj HealthCare | 10.89B |